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Fragile-X syndrome is the most commonly inherited cause of autism and mental disabilities. The Fmr1
(Fragile-X Mental Retardation 1) gene is essential in humans and Drosophila for the maintenance of neural
stem cells, and Fmr1 loss results in neurological and reproductive developmental defects in humans and
ﬂies. FMRP (Fragile-X Mental Retardation Protein) is a nucleo-cytoplasmic shuttling protein, involved in
mRNA silencing and translational repression. Both Zfrp8 and Fmr1 have essential functions in the Dro-
sophila ovary. In this study, we identiﬁed FMRP, Nuﬁp (Nuclear Fragile-X Mental Retardation Protein-
interacting Protein) and Tral (Trailer Hitch) as components of a Zfrp8 protein complex. We show that
Zfrp8 is required in the nucleus, and controls localization of FMRP in the cytoplasm. In addition, we
demonstrate that Zfrp8 genetically interacts with Fmr1 and tral in an antagonistic manner. Zfrp8 and
FMRP both control heterochromatin packaging, also in opposite ways. We propose that Zfrp8 functions as
a chaperone, controlling protein complexes involved in RNA processing in the nucleus.
& 2016 Elsevier Inc. All rights reserved.1. Introduction
Stem cell maintenance is essential for the generation of cells
with high rates of renewal, such as blood and intestinal cells, and
for the regeneration of many organs such as the brain and skin. We
have previously shown that Zfrp8 is essential for maintaining
hematopoietic, follicle, and germline stem cells (GSCs) in Droso-
phila melanogaster (Minakhina et al., 2014; Minakhina and Stew-
ard, 2010). Knockdown (KD) of Zfrp8 in GSCs results in the loss of
stem cell self-renewal, followed by the eventual loss of all germ-
line cells (Minakhina et al., 2014). Similarly in vertebrates, the
Zfrp8 homolog, Pdcd2, is essential for embryonic stem cell main-
tenance and the growth of mouse embryonic ﬁbroblasts; Pdcd2
mouse embryos die before implantation (Granier et al., 2014; Mu
et al., 2010). PDCD2 is abundantly expressed and essential in
highly proliferative cells including cultured cells and clinical iso-
lates obtained from patients with hematologic malignancies
(Barboza et al., 2013). The function of Zfrp8 and PDCD2 is highly
conserved, as expression of transgenic PDCD2 is sufﬁcient to res-
cue Zfrp8 phenotypes (Minakhina et al., 2014). Zfrp8 directly binds
to Ribosomal Protein 2 (RpS2), a component of the small ribosomal
subunit (40S), controls its stability and localization, and hence RNA
processing (personal communication with Svetlana Minakhina).
Zfrp8 also interacts with the piRNA pathway, which is conserved. Steward).throughout all metazoans and is also essential for the maintenance
of GSCs (Cox et al., 1998).
The piRNA pathway functions in maintaining heterochromatin
stability and regulating the expression levels of retrotransposons.
Both processes are thought to occur through piRNA targeting of
chromatin modifying factors to the DNA. Guided by piRNAs, the
piRNA pathway protein Piwi and associated proteins can set re-
pressive epigenetic modiﬁcations to block transcription of nearby
genes (Klenov et al., 2007; Le Thomas et al., 2013). Levels of
transposon transcripts are also controlled by cytoplasmic PIWI-
piRNA complexes, which can bind complementary mRNAs and
mark them for translational repression and degradation (Lim et al.,
2009; Rouget et al., 2010).
Fragile-X Mental Retardation Protein (FMRP) functions as a
translational repressor involved in RNA silencing [reviewed in
(Pimental and Tiossi, 2014)]. FMRP is a Piwi interactor and part of
the piRNA pathway (Bozzetti et al., 2015; Megosh et al., 2006).
FMRP-deﬁcient animals display phenotypes similar to piRNA
pathway mutants including genomic instability and de-repression
of retrotransposons (Bozzetti et al., 2015; Deshpande et al., 2006).
While FMRP is predominantly localized within the cytoplasm,
FMRP complexes have also been demonstrated within the nucleus.
In Xenopus, FMRP has been shown to bind target mRNAs co-
transcriptionally in the nucleus (Kim et al., 2009). Like Zfrp8, FMRP
has been shown to bind ribosomal proteins prior to nuclear export
(Chen et al., 2014; Taha et al., 2014). In the cytoplasm, the FMRP-
containing RNP complex controls mRNAs stability, localization,
and miRNA-dependent repression (Chen et al., 2014; Napoli et al.,
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dies show low overlap of putative targets in neuronal tissues
(Brown et al., 2001; Chen et al., 2003; Darnell et al., 2001, 2011;
Miyashiro et al., 2003).
In Drosophila, FMRP is required to maintain GSCs, and loss of
Fmr1 is associated with infertility and developmental defects in
oogenesis and neural development (Callan et al., 2010; Costa et al.,
2005; Wang et al., 2008; Yang et al., 2007). Fmr1, the gene en-
coding FMRP, is essential in both vertebrates and Drosophila for the
maintenance of neural stem cells (NSCs) (Callan et al., 2010; Luo
et al., 2010; Tervonen et al., 2010). In humans, loss of FMRP is
associated with Fragile X-associated disorders, which cover a
spectrum of mental, motor, and reproductive disabilities [reviewed
in (Kidd et al., 2014; Santos et al., 2014; Sherman et al., 2014)].
Fragile X-associated disorders are the most commonly inherited
cause of mental disabilities and autism (Hagerman, 2008). In
vertebrates, FMRP physically interacts in the nucleus with NUFIP1
(Nuclear FMRP-Interacting Protein 1), a nucleo-cytoplasmic shut-
tling protein involved in ribonucleoprotein (RNP) complex for-
mation (Bardoni et al., 2003; Boulon et al., 2008; McKeegan et al.,
2009; Rothe et al., 2014). NUFIP1 is found in the nucleus in
proximity to nascent RNA, and in the cytoplasm associated with
ribosomes (Bardoni et al., 2003). In the cytoplasm, FMRP co-lo-
calizes and associates with Trailer Hitch (Tral) to form a transla-
tional repressor complex (Barbee et al., 2006). The Tral complex
contains a number of translational repressor proteins, which to-
gether control the initiation of translation and the stability of
mRNAs, such as gurken (grk) (Barbee et al., 2006; Jeske et al., 2011;
Rouget et al., 2010; Wilhelm et al., 2005). In Drosophila, loss of Tral
causes ovary phenotypes similar to piRNA pathway mutants, in-
cluding oocyte polarity defects and transposon activation (Kugler
et al., 2009; Liu et al., 2011; Snee and Macdonald, 2009).
In this study we identiﬁed Zfrp8 interactors by performing a
yeast-two hybrid screen, and also by analyzing the components of
the Zfrp8 complex by mass spectrometry. The nature of the pro-
teins in the Zfrp8 complex indicates that it is involved in mRNA
metabolism and translational regulation. We found that Zfrp8,
Nuﬁp, FMRP, and Tral are all part of the complex and we show that
Zfrp8 interacts antagonistically with Fmr1 and tral, suppressing
their oogenesis defects. Furthermore, we determined that Zfrp8 is
required within the nucleus, and controls FMRP localization within
the cytoplasm. We further conﬁrm that FMRP functions in het-
erochromatin silencing and that Zfrp8 is required in the same
process, but has an opposite function of FMRP. We propose that
Zfrp8 functions as a chaperone of the FMRP’ containing RNP
translational repression complex and controls the temporal and
spatial activity of this complex.2. Materials and methods
2.1. Fly lines and genetic interactions
Germline expressing VALIUM22 constructs were used for RNAi
experiments. UAS- Zfrp8 RNAi (TRiP# GL00541, BDSC# 36581) and
UAS-tral RNAi lines (TRiP# GL00680, BDSC# 38908) were obtained
from the TRiP at Harvard Medical School, Boston, MA, USA. The
hsp70-Gal4 driver (P[GAL4-Hsp70.PB]89-2-1), Df(3R)Exel6265, and
PEV reporters (P[hsp26-pt-T, hsp-70wþ]118E10-C4, P[hsp26-pt-T,
hsp-70wþ]118E15-T4) were obtained from the Bloomington Stock
Center. The nos-Gal4 driver (P[GAL4::VP16-nos.UTR]) was obtained
from T. Schupbach (Princeton, NJ, USA). The Fmr13 line was a gift
from T.A. Jongens (Philadelphia, PA, USA) and the Fmr1Δ50 M line
was from D.C. Zarnescu (Tucson, AZ, USA). The Df(3R)Exel6265 line
was obtained from the Bloomington Stock Center (BDSC# 7732).
The Tral-GFP reporter protein trap line (P[wþmC¼PTT-un1]G00140)was received from L. Cooley and the FlyTrap Project (New Haven,
CT, USA) (Morin et al., 2001). In all experiments w118 ﬂies were
used as wild type controls.
For egg phenotype and fertility assays, 1 day-old females and
males were set up on egglay plates and were changed daily over
5 days. The number of eggs laid was counted when the plate was
changed and egg phenotypes and fertility rates were assessed
2 days later. Ventralization phenotypes were scored as previously
described (Li et al., 2014).3. Zfrp8 constructs
The Zfrp8 coding region was ampliﬁed by RT-PCR and cloned
into a Gateway pENTR4 (Life Technologies) vector. Zfrp8 deletion
constructs were created via PCR site-directed mutagenesis. The
Zfrp8 NLS deletion construct removes putative NLS sequences at
residues 100–106 and 246–263. The Zfrp8 NES deletion construct
removes a putative NES sequence at residues 304–317. Deletion
constructs were then cloned into pUAS-TAP-mCherryW-attB vector
for injections (Hudson and Cooley, 2010).
For targeted Zfrp8 constructs, A GFP coding sequence was then
subcloned at the 5′ end of Zfrp8 to create pENTR4-GFP-Zfrp8
(Gateway). To create membrane-localized CD8-GFP-Zfrp8, trans-
genic mouse CD8a was ampliﬁed from y1w*; P[UAS-mCD8::GFP.L]
LL5 (BDSC #5137) and subcloned at the 5′ end of the GFP coding
sequence (Lee and Luo, 1999). Nuclear-localized GFP-NLS-Zfrp8 and
cytoplasmic-localized GFP-NES-Zfrp8 constructs were created by
amplifying pENTR-GFP-Zfrp8 via circular PCR, using primers with
extended 5′ NLS and NES coding sequences, respectively. The NLS
sequence encodes the SV40 Large T-antigen monopartite NLS,
PKKKRKV (Kalderon et al., 1984). The NES sequence encodes the
HIV-1 Rev NES, LPPLERLTLD (Fischer et al., 1995). The inserts were
transferred into pUASg-attB plasmids using the Invitrogen Gateway
Cloning System (Bischof et al., 2013). Transgenic ﬂy lines were
created via PhiC31 integrase-mediated transgenesis inserted into
the attP2 landing site (Groth et al., 2004) by Genetics Services, Inc.
at Cambridge, MA, USA.
For targeted rescue experiments, transgenic Zfrp8 lines were
crossed to hsp70-Gal4 in a Zfrp8 mutant background and raised at
25 °C. Viability was calculated by comparing the number of actual
eclosed adults to total expected adults. For mutational analysis and
genetic interaction experiments, crosses were raised until eclosion
at 29 °C, and subsequently maintained as adults at 25 °C until
examination.4. Position effect variegation
Ethanol-based pigment extraction and quantiﬁcation was per-
formed as described in Sun et al. (2004) with minor modiﬁcations.
Flies were homogenized in 250 ul pigment assay buffer, followed
by incubation at room temperature for 1 h for pigment extraction.
A ﬁnal volume of 200 ul of pigment extract was used to read OD at
480 nm. For each assay, data from 3 samples (each sample made
up of twenty 3 day old ﬂies, randomly picked from the population)
were collected.5. Protein puriﬁcation and mass spectrometry
To isolate the Zfrp8 protein complex, tandem afﬁnity puriﬁca-
tion (TAP) was done as described in (Burckstummer et al., 2006;
Kyriakakis et al., 2008; Veraksa et al., 2005). Zfrp8 was cloned into
pUAST-NTAP (Veraksa et al., 2005). Transgenic ﬂies carrying pUAST-
NTAP-Zfrp8 were generated using standard methods (Brand and
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driver was sufﬁcient to rescue Zfrp8 lethality and sterility. Extracts
of da-Gal4/UAS-NTAP-Zfrp8 and w118 (control) 0–12 h embryos
were used for two step afﬁnity puriﬁcation. Proteins were sepa-
rated by SDS-PAGE and bands visualized by Coomassie staining. To
eliminate the contribution from IgG and Zfrp8 itself, fragments
from 60–200 kD and from 15–35 kD were cut from the gel and
analyzed by the Biological Mass Spectrometry Facility of the Uni-
versity of Medicine and Dentistry of New Jersey–Rutgers for LC-
MS/MS analysis. Positive proteins were represented by Z5 pep-
tides in Zfrp8 fractions and also r1 peptides in the vector only
control.
Nuﬁp was cloned into the pMK33-NTAP vector (Veraksa et al.,
2005). Drosophila S2 cells were transfected with either pMK33-
NTAP-Nuﬁp or the vector alone (as a control). After transfection
and selection of stable cell lines, cells were grown for 8 days at
18 °C before lysis and tandem afﬁnity puriﬁcation. Input and im-
munoprecipitation fractions were probed with anti-FMRP and
anti-Zfrp8 antibodies.
For co-immunoprecipitation experiments, human NUFIP1 was
cloned into a pCDNA 3xFLAG vector. After transfection of HEK293
cells with this construct or the empty vector, cells were grown for
72 h at 37 °C before lysis and immunoprecipitation using a Sigma-
Aldrich FLAG Immunoprecipitation Kit as described in the manu-
facturer's instructions. Extracts from cells transfected with the
empty FLAG tag vector were used as negative controls. Input and
immunoprecipitation fractions were probed on western blot with
anti-FLAG and anti-PDCD2 antibodies.6. Yeast two-hybrid screen
The PDCD2 yeast two-hybrid screen was performed using the
Matchmaker Gold Protocol Yeast-Two Hybrid System (Clontech
#630489). Matchmaker uses 4 different reporters each under the
control of a distinct and separate cell cycle-responsive promoter,
M1-expressing AUR1-C (Aureobasidin A/AbA resistance), M1-ex-
pressing MEL1 (α-galactosidase), G1-expressing HIS3 (histidine
biosynthesis) and G2-expressing ADE2 (adenine biosynthesis). For
bait, full-length human PDCD2 was cloned into the pGBKT7 vector.
Expression of PDCD2 in yeast cells was conﬁrmed by Western
blotting using anti-PDCD2, and tested negative for auto-activation
and toxicity. The pGBKT7-PDCD2 construct was then mated to a
Mate and Plate normalized mouse embryonic stem cell library
(Clontech #630484). Mated yeast culture was plated onto low-
stringency plates containing minimal, synthetically deﬁned (SD)
-Leu/-Trp/X-α-Gal/AbA. Positive colonies were conﬁrmed on high-
stringency plates containing (SD) -Ade/-His/-Leu/-Trp/X-α-Gal/
AbA. Positive plasmids were then isolated and retested with
pGBKT7-PDCD2 on high stringency plates for ﬁnal conﬁrmation.
Retested positives were then sequenced to identify PDCD2
interactors.7. Protein prediction software
Ortholog prediction was completed using DIOPT- DRSC In-
tegrative Ortholog Prediction Tool (Hu et al., 2011). Prediction of
Zfrp8 nuclear localization signals was completed using cNLS
Mapper (Kosugi et al., 2009). Prediction of Zfrp8 nuclear export
signal was completed using ExPASy NetNES (la Cour et al., 2004).
8. Immunostaining and microscopy
For immunostaining, ovaries were dissected from either virgins
(o12 h) or at 7 days after eclosion, as indicated. Lymph glandswere dissected from third instar larvae. For each immunostaining
experiment, a minimum of 15 samples were analyzed.
Rabbit anti-Zfrp8 antibody was used at 1:2500 (Minakhina
et al., 2014). Monoclonal mouse anti-FMRP 5B6 (DSHB, University
of Iowa) was used at 1:1000. Monoclonal mouse anti-FLAG M2
(Sigma) was used at 1:1000. Polyclonal rabbit anti-PDCD2
(1:1000) was a gift from P.A. Sharp (Cambridge, MA, USA) (Scarr
and Sharp, 2002). Alexa Fluor 488 Phalloidin (Invitrogen) and
secondary antibodies (Jackson Laboratories) were used at 1:300.
Hoechst 33258 (1:5000) was used to stain DNA. Ovary im-
munostaining images were captured using a Leica TCS SP5 laser
scanning confocal microscope (at 63oil), analyzed with Leica
Microsystems software and processed using Adobe Photoshop. Egg
phenotype images were captured using a Zeiss SteREO Discovery.
V8 stereomicroscope (at 5 ), analyzed with ProgRes Mac Cap-
turePro 2.6 software and processed using Adobe Photoshop.9. Quantitative RT-PCR
Quantitative RT-PCR was performed as described in the man-
ufacturer instructions using the QuantiTect SYBR Green kit (Qia-
gen), Smart Cycler II (Cepheid) and the relative standard curve
method. RNA was isolated from 10–20 virgin ovaries (o12 h old)
using Qiagen RNeasy Plus Mini kits. Conﬁrming knockdown in the
tral RNAi line, we quantiﬁed tral expression in nos-Gal4/UAS-tral
RNAi at 0.32070.045s.d., compared to nos-Gal4/þ expression at
1.04370.053s.d. from whole ovaries. w118 control ovaries used as
the baseline (equal to 1). Transcript levels were normalized to
those of Gapdh1. A minimum of two biological and two technical
replicates were performed for each genotype. Primers used for tral
qPCR were: AAATGCCACAACCGCGAC, AAAGTGGCTTTCCACTGGC10. Results and discussion
10.1. Nuﬁp and FMRP are components of the Zfrp8 protein complex
Zfrp8 is essential for stem cell maintenance, but its molecular
functions have not yet been clearly deﬁned (Minakhina et al.,
2014; Minakhina and Steward, 2010). In order to address this
question we used two distinct approaches. We performed a yeast-
two hybrid screen to identify direct interactors of Zfrp8 and we
also characterized the components of the Zfrp8 complex by mass
spectrometry.
Because of the high sequence and functional conservation of
Zfrp8 (ﬂies) and PDCD2 (mammals) (Minakhina et al., 2014), and
because no stem cell-derived cDNA library exists in Drosophila, we
decided to screen a mouse embryonic stem cell cDNA library using
mammalian PDCD2 as bait (see Materials and Methods). We iso-
lated 46 initial positives, and identiﬁed 19 potential interactors
after re-testing of the positives (Supplemental Table 1).
In order to purify the Zfrp8 protein complex we established a
transgenic line expressing NTAP-tagged Zfrp8 under the control of
the general da-Gal4 (daughterless) driver. Two-step tandem afﬁnity
puriﬁcation was performed on embryonic extracts and the puriﬁed
proteins were separated by SDS-PAGE electrophoresis. The pro-
teins were eluted and analyzed by mass spectrometry (see Mate-
rials and Methods). Thirty proteins were identiﬁed as part of the
Zfrp8 complex. The threshold for interactors was set to at least 5
peptide enrichment in Zfrp8 over vector control fractions (Table 1).
Eighteen of the proteins are predicted to function in ribosomal
assembly or translational regulation, strongly suggestive of a
function of Zfrp8 in mRNA processing (i.e. translation, localization,
and stability). In the complex we found six ribosomal subunits
(ﬁve 40S subunits and one 60S subunit); EF2 and eIF-4a, which are
Table 1
Zfrp8 interactors identiﬁed by TAP puriﬁcation followed by mass spectrometry.
Symbol Protein Human Ortholog # Peptides
matched*
Estimated mass
(kD)
Molecular function
Act42A Actin 42A ACTB/G1 33 41.8 Cytoskeletal protein
AP-2α AP-2 complex subunit alpha AP2A2 10 105.6 Endocytosis
CkIα Casein kinase I isoform alpha CSNK1A1 21 39.5 Protein kinase
Ef1γ Elongation factor 1-gamma EEF1G 23 49.0 Regulation of organelle transport Serpinskaya et al. (2013)
EF2 Elongation factor 2 EEF2 18 94.5 Translation elongation factor
eIF-4a Eukaryotic initiation factor 4A EIF4A1/2 24 45.9 Translation initiation factor
FK506-bp1 39 kDa FK506-binding nuclear
protein
12 39.3 Prolyl isomerase
FMRP Fragile-X mental retardation
protein
FMR1 8 72.0 Translational regulation, Rm62-interactor Zhang et al.
(2001); Ishizuka et al. (2002)
Glo Glorund HNRNPH1 39 61.4 Gurken mRNA localization and translational repression Kalifa
et al. (2009)
Hrb27C Heterogeneous nuclear ribonu-
cleoprotein 27C
DAZAP1 26 44.8 Gurken mRNA localization Goodrich et al. (2004)
Hrb87F Heterogeneous nuclear ribonu-
cleoprotein 87F
HNRNPA2B1 50 39.5 Ribonucleoprotein, NonA-interactor Reim et al. (1999)
Hsc70-4 Heat shock 70 kDa protein cog-
nate 4
23 71.1 Chaperone protein
Hsp83 Heat shock protein 83 HSP90AA1/B1 8 81.9 Chaperone protein, regulation of piRNA pathway Gangaraju
et al. (2011)
Map205 205 kDa microtubule-associated
protein
25 126.7 Cytoskeletal protein
Nep1 Neprilysin 1 MME/L1 31 96.5 Peptidase
NonA Protein no-on-transient A SFPQ 163 77.0 RNP nucleo-cytoplasmic shuttling Kozlova et al. (2006)
Nop60B Nucleolar protein at 60B DKC1 54 56.8 Ribosomal RNA processing Giordano et al. (1999)
Nopp140 Nopp140 NOLC1 34 70.5 Ribosome assembly and repression of transposon expression
He et al. (2014)
Pug Pugilist MTHFD1 20 103.5 Tetrahydrofolate conversion
Rm62 Rm62 DDX17 68 50.0 RNA helicase, FMRP-interactor Ishizuka et al. (2002)
RpL7A Ribosomal protein L7A RPL7A 7 30.7 Ribosomal protein
RpS2 Ribosomal protein S2 RPS2 224 28.9 Ribosomal protein (Cramton and Laski (1994)
RpS3 Ribosomal protein S3 RPS3 15 27.5 Ribosomal protein
RpS4 Ribosomal protein S4 RPS4 32 29.1 Ribosomal protein
RpS5a 40S ribosomal protein S5a RPS5 11 25.4 Ribosomal protein
RpS7 Ribosomal protein S7 RPS7 18 22.2 Ribosomal protein
Top2 DNA topoisomerase 2 TOP2A/B 59 164.4 Topoisomerase
Tral Trailer hitch LSM14A/B 80 69.3 Secretory pathway regulation; Repression of transposon ex-
pression, FMRP-interactor (Kugler et al. (2009); Liu et al.
(2011)
αTub84B Alpha-tubulin at 84B TUBA3C/D 5 49.9 Cytoskeletal protein
βTub56D Beta-tubulin at 56D TUBB4B 8 51.3 Cytoskeletal protein
n For all proteins, r1 peptides were found in the vector-only TAP control.
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and Glorund which function in mRNA transport and translational
repression. While Zfrp8 interacts with several ribosomal proteins
it does not appear to be part of the ribosome itself (Marygold et al.,
2007).
No overlapping interactors were found in our yeast-two hybrid
screen and mass spectrometry assay. But interestingly, FMRP was
identiﬁed as part of the Zfrp8 complex by mass spectrometry and
NUFIP1 in our yeast-two hybrid assay. Most likely Nuﬁp (estimated
57 kD) was not identiﬁed as part of the Zfrp8 complex in the TAP-
puriﬁcation approach, because we excluded proteins with similar
size to tagged Zfrp8 (55 kD) from the mass spectrometry ana-
lysis. To investigate whether these proteins could work together in
the same molecular process we conﬁrmed the interaction of both
Zfrp8 and PDCD2 with Nuﬁp (ﬂies) and NUFIP1 (mammals) in
tissue culture cells. Immunoprecipitation of human HEK293 cell
extracts expressing FLAG-tagged NUFIP1 pulled down endogenous
PDCD2 (Fig. 1A). We next examined whether this protein inter-
action also exists in Drosophila. We were able to co-purify en-
dogenous Zfrp8 with NTAP-tagged Nuﬁp from transfected S2 cells
(Fig. 1B). We then performed an additional Western blot on the
puriﬁed NTAP-Nuﬁp isolate and could show that FMRP is presentin the protein complex (Fig. 1B), indicating that Nuﬁp physically
interacts with both Zfrp8 and FMRP. Our results suggest that all
three proteins function together in a molecular complex which
regulates RNP processing/assembly and translation. Based on
these results, and the requirement of both Zfrp8 and Fmr1 in stem
cell maintenance, we decided to characterize the genetic interac-
tion between these genes.11. Loss of Zfrp8 suppresses Fmr1 infertility and ovary defects
To further characterize the connection between the two genes,
we examined whether the loss of Zfrp8 can modify oogenesis
defects reported for Fmr1 females (Costa et al., 2005). Similar to
what was previously reported, 100% of Fmr1Δ50M/Df(3 R)Exel6265
(N¼26) and 80% of Fmr1Δ50M/Fmr13 (N¼22) ovaries displayed
developmental defects (Costa et al., 2005). The ovarioles contained
fused egg chambers (100%, 64% for each genotype, respectively;
Fig. 2C and E, bracket), aberrant nurse cell numbers (46%, 32%;
Fig. 2C and E, arrow). We occasionally also observed egg chambers
with oocyte misspeciﬁcation/multiple oocytes (o20%, not
shown). Interestingly, the loss of one copy of Zfrp8 suppressed the
Fig. 1. Nuﬁp and FMRP are components of the Zfrp8 complex. A. Western blot
displaying the immunoprecipitation of human PDCD2 with FLAG-tagged NUFIP1
from HEK293 cell extracts. Negative control: extract from cells transfected with the
empty FLAG-tag vector. B. NTAP-tagged Drosophila Nuﬁp was expressed in S2 cells
and puriﬁed. Protein complex is visualized on western blot with anti-FMRP and
anti-Zfrp8 antibodies. Negative control: extract from cells transfected with the
empty NTAP-tag vector. IN – total extract, IP immunoprecipitate, PU puriﬁed
complex.
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germline, as well as egg chamber morphology and separation
(Fig. 2D and F). In Zfrp8/þ; Fmr1Δ50M/Df(3R)6265 (N¼20), fusion of
the ﬁrst egg chamber is still observed in most germaria, but de-
spite this, oogenesis appears to proceed normally resulting in
normal looking ovarioles (Fig. 2D, bracket). Zfrp8/þ ;
Fmr1Δ50M/Fmr13 (N¼33) ovaries appear almost completely normal
even though these ovarioles contain no FMRP (Fig. 2F).
The loss of Fmr1 has also been associated with a strong re-
duction in egg production (Bauer et al., 2008; Zhang et al., 2004).
We found that similar to previous reports, Fmr1Δ50M/Df(3R)
Exel6265 and Fmr1Δ50M/Fmr13 mutants display a strong reduction
in fertility; females laid on average of 1 and 6 eggs/day, respec-
tively, as compared to 18 eggs/day for wild-type ﬂies (Table 2). The
removal of one copy of Zfrp8 partially suppressed Fmr1 infertility
and resulted in 8 eggs/day from Fmr1Δ50M/Df(3R)Exel6265 and 15
eggs/day from Fmr1Δ50M/Fmr13 females. These results demonstrate
that Zfrp8 and Fmr1 affect the same process and that even though
they are found in the same complex, have opposing functions.12. Zfrp8 is required for proper FMRP localization
To investigate the nature of the Zfrp8 interaction with FMRP,
we examined the localization of the proteins within the ovary. As
we have shown previously, Zfrp8 displays ubiquitous distribution
in all cells and cell compartments of the wild type ovary (Fig. 3A, A
′). No signiﬁcant changes in Zfrp8 localization or levels are visible
in Fmr1 ovaries (Fig. 3B, B′). FMRP has a more varied distribution
pattern, present in strong, cytoplasmic puncta in the cytoplasm of
nurse cells and follicle cells (Fig. 3A, A′′, E, E′), and also in high
levels in the cytoplasm of the maturing oocyte (3E, E′). FMRP is
also detectable in low levels in nurse cell nuclei at stage 8 eggchambers at an average of 9.76 puncta per nucleus (N¼80). As
expected, Fmr1 ovaries display no FMRP staining in either the
cytoplasm or nucleus (Fig. 3B, B′′, F, F′,).
To determine whether Zfrp8 functions in FMRP regulation, we
depleted Zfrp8 in the germline by expressing Zfrp8 RNAi under the
control of the nos-Gal4 driver (Minakhina et al., 2014), and as-
sessed changes in FMRP expression. In control nos-Gal4 ovaries,
FMRP levels and distribution were similar to that in wild-type
ovaries (Fig. 3C, C′′, G, G′). However, in Zfrp8 KD ovaries, aberrant
FMRP localization is observed in the germline; FMRP is more
uniformly distributed throughout the cytoplasm and puncta are
strongly diminished (Fig. 3D, D′′, H, H′). Remaining FMRP puncta
appear fragmented, reduced in intensity, size and number (10%
of wild-type; N¼22 egg chambers counted). These results indicate
a Zfrp8 requirement for proper FMRP localization to the cytoplasm.
FMRP normally functions by shuttling mRNA cargo from the nu-
cleus to the cytoplasm, where it represses the translation of bound
mRNA. The observed change of FMRP localization in Zfrp8 KD
ovaries therefore may indicate a regulatory function for Zfrp8 in
the nuclear export and localization of FMRP.13. Zfrp8 is required in the nucleus
Zfrp8 protein is present in both the cytoplasm and nucleus
(Fig. 3A, A′) (Minakhina et al., 2014) and, as demonstrated above,
controls the distribution of FMRP in the cytoplasm. We decided to
investigate the cell compartment in which Zfrp8 is required, in
order to elucidate how Zfrp8 regulates FMRP. To do so, we ex-
amined the capability of Zfrp8 deletion constructs to rescue mu-
tant lethality. Expression of human PDCD2 cDNAs driven by the
general driver da-Gal4 is fully capable of rescuing Zfrp8 lethality
(Barboza et al., 2013; Minakhina et al., 2014). We created mutated
Zfrp8 constructs, removing either the two putative NLSs or the
putative NES domains. These proteins were expressed under the
da-Gal4 driver, and while clearly overexpressed on Western blots,
failed to rescue mutant lethality, suggesting that the three do-
mains are essential for the function of the protein (not shown).
In an alternative approach, we assayed the function of Zfrp8
proteins targeted to a distinct cell compartment. We expressed
four N-terminal GFP-tagged transgenic proteins encoding a wild-
type Zfrp8, nuclear-localized NLS-Zfrp8, cytoplasmic-localized
NES-Zfrp8, and cell membrane-localized CD8-GFP-Zfrp8. Trans-
genic Zfrp8 subcellular localization is visible when the proteins are
strongly overexpressed (Supplemental Fig. 1A–D). When we ex-
pressed the transgenes at lower levels, similar to the endogenous
levels, with the hsp70-Gal4 driver at 25 °C, both wild-type and
nuclear-localized Zfrp8 were able to rescue mutant lethality at
similar rates, whereas the cytoplasmic- and membrane-localized
proteins did not show rescue (Supplemental Table 2). These results
show that Zfrp8 is required in the nucleus and suggest that like
FMRP, Zfrp8 may function by shuttling between nuclear and cy-
toplasmic compartments.14. Zfrp8 suppresses the Tral oogenesis phenotypes
We have shown that FMRP and Zfrp8 are present in the same
protein complex. In addition to FMRP, our mass spectrometry re-
sults have also identiﬁed other translational regulators, such as
Tral. Tral has previously been shown to function in conjunction
with FMRP to control the translation of mRNAs (Barbee et al.,
2006).
To determine whether Zfrp8 functions in Tral/FMRP-associated
translational regulation, we investigated the genetic interaction
between Zfrp8 and tral. Tral regulates dorsal-ventral (D/V)
Fig. 2. Loss of Zfrp8 suppresses Fmr1 infertility and ovary defects. A. Wild-type ovariole comprised of a normal germarium and early egg chambers. B. Zfrp8null/þ het-
erozygote ovarioles do not display any morphological defects. C. Fmr1Δ50M/Df(3R)Exel6265 ovarioles displays a disorganized germarium, often fused to an egg chamber
containing more than the normal 15 nurse cells (bracket and arrow). D. Zfrp8null/þ ; Fmr1Δ50M/Df(3R)Exel6265 ovarioles show suppression of the Fmr1Δ50M/Df(3R)Exel6265
morphological defects. While the ﬁrst egg chamber often remains fused to the germarium (bracket), the later stages of oogenesis are normal. E. Fmr1Δ50M/Fmr13 ovariole
containing a fused germarium-egg chamber (bracket) and an egg chamber with abnormal numbers of nurse cells (arrow). F. Zfrp8null/þ; Fmr1Δ50M/Fmr13 exhibit mor-
phologically normal ovarioles. DNA (blue); ﬁlamentous actin-phalloidin (green). Confocal sections are shown; scale bar: 10 uM.
Table 2
Zfrp8 suppresses Fmr1 egg laying defects.
Genotype Hatch rate Eggs laid
per day
Eggs
counted
w118 95.10% 18.01 n¼1801
Fmr1Δ50M/þ 91.68% 16.84 n¼317
Df(3R)Exel6265/þ 90.79% 12.75 n¼956
Fmr1Δ50M/Df(3R)Exel6265 94.85% 0.97 n¼97
Zfrp8null/þ ; Fmr1Δ50M/Df(3R)Exel6265 85.99% 8.28 n¼236
Fmr1Δ50M/Fmr13 89.55% 5.74 n¼145
Zfrp8null/þ ; Fmr1Δ50M/Fmr13 78.48% 15.14 n¼336
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gurken (grk) mRNA (Wilhelm et al., 2005). Eggs laid by tral females
display ventralized chorion phenotypes, due to the aberrant Gurken
morphogen gradient. If Zfrp8 functions to regulate the translational
activity of FMRP/Tral, a suppression of the tral ventralized pheno-
types should be apparent when Zfrp8 is reduced. We depleted Tral
in the germline by expressing a TRiP RNAi line (see Material and
Methods) under the control of the nos-Gal4 driver. Tral KD resulted
in similar ventralized egg phenotypes as previously observed in
eggs laid by tral1 females (Wilhelm et al., 2005): 1% of eggs dis-
played two normal dorsal appendages (Wt), 36% had fused ap-
pendages (category V2/V3), and 63% had no dorsal appendages
(category V4, see Materials and Methods) (Fig. 4A and B). Removing
one copy of Zfrp8 in the tral KD background suppressed the tral
phenotypes (17% Wt, 53% V2/V3, and 30% V4, Fig. 4A and B). This
genetic interaction suggests that in addition to controlling the lo-
calization of FMRP in the cytoplasm, Zfrp8 also inﬂuences thetranslational control by Tral, essential for formation of dorsal-ven-
tral polarity in the egg (Wilhelm et al., 2005).
We investigated whether Zfrp8 regulates Tral localization as it
does FMRP by examining the distribution of GFP-fusion Tral pro-
tein trap line (Morin et al., 2001). Tral protein was uniformly
present in cytoplasmic compartments of germline and somatic
cells, with stronger granules surrounding nuclei, and was highly
enriched within the oocyte (Supplemental Fig. 3A and C). Zfrp8 KD
results in loss of oocyte identity (Minakhina et al., 2014), and the
distribution of Tral was signiﬁcantly altered in those cells. But in
all other germline cells Tral distribution remained unaffected
(Supplemental Fig. 3B and D). Tral and its orthologs are cyto-
plasmic proteins (Wilhelm et al., 2005) and examination of the
Tral protein sequence identiﬁes no NLSs. Zfrp8 may therefore in-
teract only indirectly with Tral and not regulate its localization.15. Zfrp8 and Fmr1 control position effect variegation
piRNA pathway genes have been shown to be essential for
heterochromatin packaging in position effect variegation (PEV)
experiments (Brower-Toland et al., 2007; Gu and Elgin, 2013). PEV
measures expression of endogenous or reporter genes inserted
within or adjacent to heterochromatin. Fmr1 is speciﬁcally re-
quired for chromatin packaging as loss of a single copy of Fmr1 is
sufﬁcient to inhibit heterochromatin silencing of a white reporter
(wþ) inserted into the pericentric heterochromatin region 118E10
on the 4th chromosome (Deshpande et al., 2006).
We analyzed PEV of Zfrp8 heterozygotes, Fmr1 heterozygotes
Fig. 3. Zfrp8 is required for proper FMRP localization. A-A′′, E-E′. In wild-type (w118) ovarioles FMRP is seen as puncta throughout the cytoplasm and at low levels in nurse
cell nuclei of stage 8 egg chambers at an average of 9.76 puncta per nucleus (N¼80), while Zfrp8 is uniformly distributed in the cytoplasm and nuclei. B-B′′, F-F′. In Fmr1Δ50M
/Df(3R)Exel6265 ovarioles FMRP protein is absent as expected both in the cytoplasm and in nuclei (N¼81), while Zfrp8 expression and distribution is not signiﬁcantly
changed. C-C′′, G-G′. Control nos-Gal4/þ ovarioles appear similar to wild-type, FMRP localizes to cytoplasmic foci;. D-D′′, H-H′. Within Zfrp8 KD egg chambers FMRP
localization to cytoplasmic puncta is disrupted and the protein is more uniformly distributed throughout the cytoplasm. Anti-Zfrp8 (green), anti-FMRP (red), DNA (blue).
Confocal sections are shown; scale bar: 10 uM.
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some centromeric) and an additional wþ reporter, inserted into
heterochromatin region 118E15 (4th chromosome telomeric).
While the wþ reporters in Zfrp8null/þ eyes were expressed at le-
vels comparable to those in wild-type controls, expression in
Fmr1Δ50M/þ of both wþ reporters was strongly enhanced. But, the
removal of one copy of both Zfrp8 and Fmr1 decreased expression
of the reporters back to the Zfrp8/þ , near wild-type levels, in-
dicating restored heterochromatin silencing of both 4th chromo-
somal insertions (Fig. 5). These ﬁndings suggest that in normal
eyes, Zfrp8 functions upstream of Fmr1 and controls Fmr1 effects
on heterochromatin packaging.
A connection between regulation of heterochromatin silencing
and Piwi has clearly been established and our results show that
Zfrp8 and FMRP are part of the mechanism that controlsheterochromatin silencing (Brower-Toland et al., 2007; Gu and
Elgin, 2013). Heterochromatin is established at the blastoderm
stage in Drosophila embryos and is subsequently maintained
throughout development. Thus, FMRP and Zfrp8 function together
in heterochromatin packaging in the early embryo in the same
way as they do during oogenesis.16. Conclusion
Here we show that Zfrp8 is part of a complex that is involved in
RNA processing, i.e. translation, localization, and stability. We
propose that Zfrp8 likely forms a ribonucleoprotein complex with
Nuﬁp, FMRP and select mRNAs in the nucleus, and is required for
localization of this complex in the cytoplasm. After nuclear export,
Fig. 4. Zfrp8 suppresses tral oogenesis phenotypes. A. w118 (Wt) egg displaying two normally spaced dorsal appendages. A ventralized egg displaying only one wider, fused
dorsal appendage (V2/V3) (Li et al., 2014). A fully ventralized egg displaying no dorsal appendages (V4). B. Loss of one copy of Zfrp8 suppresses the tral dorsal-ventral egg
phenotype.
Fig. 5. Zfrp8 and Fmr1 control Position Effect Variegation (PEV). A. Eyes of ﬂy expressing the PEV reporter [wþ]118E15-4T in w; w, Zfrp8null/þ; w, Fmr150M/þ; w, Zfrp8null/þ ,
Fmr150M/þ backgrounds. B. Eyes of ﬂy expressing the PEV reporter [wþ]118E10-4C in w; w, Zfrp8null/þ ; w, Fmr150M/þ; w, Zfrp8null/þ , Fmr150M/þ backgrounds. The ex-
pression of both reporters is unchanged in the Zfrp8null/þ background, while the expression is enhanced in the Fmr150M/þ background. In a Zfrp8null/þ , Fmr150M/þ
background, expression is suppressed compared to Fmr150M/þ alone. Measurement of eye color (OD 480 nm) of extracts from corresponding ﬂy heads support the result.
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and repression by FMRP and Tral. The suppression of the Fmr1 and
tral phenotypes in a Zfrp8 heterozygous background, occurs in the
absence of Fmr1 and the strong reduction of tral. This suggests that
Zfrp8 function is not protein speciﬁc, but rather that it controls the
FMRP and Tral-associated complex, even in the absence of each ofthe two proteins. Our hypothesis is consistent with Zfrp8 actively
controlling the localization of FMRP to cytoplasmic foci, as this
localization is affected in Zfrp8 germ cells.
We have previously identiﬁed a piRNA pathway protein,
Maelstrom (Mael), that is controlled by Zfrp8 in a similar manner
as FMRP. Zfrp8 forms a protein complex with Mael, genetically
Fig. 6. Model of the requirement of Zfrp8 and associated proteins.
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nuage, a perinuclear structure (Minakhina et al., 2014). But the
Zfrp8 phenotype is stronger and appears earlier than that of mael,
tral, Fmr1, or other piRNA pathway regulatory genes we have
studied so far. Zfrp8 may therefore control a central step in the
regulation of speciﬁc RNPs. Consistent with this hypothesis, our
TAP puriﬁcation and mass spectrometry analysis identiﬁed a
number of Zfrp8-associated proteins, the majority of which func-
tion in ribosomal assembly or translational regulation, such as the
ribosomal protein RpS2. And Zfrp8 KD in the germ line and partial
loss of rps2 result in a similar “string of pearls phenotype”, caused
by developmental arrest in early stages of oogenesis (Cramton and
Laski, 1994; Minakhina et al., 2014). In addition, a recent study has
shown that Zfrp8 and PDCD2 contain a TYPP (TSR4 in yeast, YwqG
in E. coli, PDCD2 and PDCD2L in vertebrates and ﬂies) domain,
which has been suggested to perform a chaperone-like function in
facilitating protein–protein interactions during RNA processing
(Burroughs and Aravind, 2014). These observations lead us to hy-
pothesize that Zfrp8 functions as a chaperone essential for the
assembly of ribosomes and the early recruitment and localization
of ribosomal-associated regulatory proteins, such as FMRP, Tral
and Mael (Fig. 6).
Zfrp8 negatively controls the functions of Fmr1 and tral. In the
absence of FMRP and Tral the temporal and spatial control of
translation of their associated RNPs is lost. We propose that re-
ducing the level of Zfrp8 diminishes the availability of these RNP-
complexes in the cytoplasm resulting in suppression of the Fmr1
and tral phenotypes.
Zfrp8, Fmr1 and tral have all been shown to genetically and
physically interact with components of the piRNA pathway, and to
regulate the expression levels of select transposable elements (Liu
et al., 2011; Megosh et al., 2006; Minakhina et al., 2014). Trans-
poson de-repression is often associated with the loss of hetero-
chromatin silencing. The molecular mechanisms underlying het-
erochromatin formation appear to involve maternally contributed
piRNAs and piRNA pathway proteins that control the setting of
epigenetic marks in the form of histone modiﬁcations, maintained
throughout development (Gu and Elgin, 2013). But transposon
expression can also be controlled post-transcriptionally by cyto-
plasmic PIWI-piRNA complexes, suggesting that transposon de-
regulation and heterochromatin silencing phenotypes seen in
FMRP and Zfrp8 may be linked to translational de-repression (Lim
et al., 2009; Rouget et al., 2010). We propose that by facilitating the
early assembly of ribosomes with speciﬁc translational repressors,
Zfrp8 regulates several developmental processes during oogenesis
and early embryogenesis including dorsal-ventral signaling,
transposon de-repression, and position effect variegation.Acknowledgments
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